Literature DB >> 15832171

Woodchuck post-transcriptional element induces nuclear export of myotonic dystrophy 3' untranslated region transcripts.

Nikolaos P Mastroyiannopoulos1, Mariana L Feldman, James B Uney, Mani S Mahadevan, Leonidas A Phylactou.   

Abstract

The woodchuck post-transcriptional regulatory element (WPRE) can naturally accumulate hepatitis transcripts in the cytoplasm, and has been recently exploited as an enhancer of transgene expression. The retention of mutant myotonic dystrophy protein kinase (DMPK) transcripts in the nucleus of myotonic dystrophy (DM) cells has an important pathogenic role in the disease, resulting in pleiotropic effects including delayed myoblast differentiation. In this study, we report the first use of WPRE as a tool to enhance nuclear export of an aberrantly retained messenger RNA. Stable cell lines expressing the normal and mutant DMPK 3' UTR (3' untranslated region) complementary DNA, with or without WPRE, were produced. It is noteworthy that WPRE stimulated extensive transport of mutant transcripts to the cytoplasm. This was associated with repair of the defective cellular MyoD levels and a subsequent increase in myoblast differentiation. These results provide the basis for a cellular model that can be exploited in DM and in the study of RNA transport mechanisms.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15832171      PMCID: PMC1299300          DOI: 10.1038/sj.embor.7400390

Source DB:  PubMed          Journal:  EMBO Rep        ISSN: 1469-221X            Impact factor:   8.807


  28 in total

1.  Increased in vitro and in vivo transgene expression levels mediated through cis-acting elements.

Authors:  Jens Johansen; Jens Tornøe; Arne Møller; Teit E Johansen
Journal:  J Gene Med       Date:  2003-12       Impact factor: 4.565

2.  Viral vector producing antisense RNA restores myotonic dystrophy myoblast functions.

Authors:  D Furling; G Doucet; M-A Langlois; L Timchenko; E Belanger; L Cossette; J Puymirat
Journal:  Gene Ther       Date:  2003-05       Impact factor: 5.250

3.  Three proteins, MBNL, MBLL and MBXL, co-localize in vivo with nuclear foci of expanded-repeat transcripts in DM1 and DM2 cells.

Authors:  Majid Fardaei; Mark T Rogers; Helena M Thorpe; Kenneth Larkin; Marion G Hamshere; Peter S Harper; J David Brook
Journal:  Hum Mol Genet       Date:  2002-04-01       Impact factor: 6.150

4.  Hammerhead ribozyme-mediated destruction of nuclear foci in myotonic dystrophy myoblasts.

Authors:  Marc-André Langlois; Nan Sook Lee; John J Rossi; Jack Puymirat
Journal:  Mol Ther       Date:  2003-05       Impact factor: 11.454

5.  Muscleblind proteins regulate alternative splicing.

Authors:  Thai H Ho; Nicolas Charlet-B; Michael G Poulos; Gopal Singh; Maurice S Swanson; Thomas A Cooper
Journal:  EMBO J       Date:  2004-07-15       Impact factor: 11.598

Review 6.  Myogenic defects in myotonic dystrophy.

Authors:  Jeffrey D Amack; Mani S Mahadevan
Journal:  Dev Biol       Date:  2004-01-15       Impact factor: 3.582

7.  A muscleblind knockout model for myotonic dystrophy.

Authors:  Rahul N Kanadia; Karen A Johnstone; Ami Mankodi; Codrin Lungu; Charles A Thornton; Douglas Esson; Adrian M Timmers; William W Hauswirth; Maurice S Swanson
Journal:  Science       Date:  2003-12-12       Impact factor: 47.728

Review 8.  Pathogenic RNA repeats: an expanding role in genetic disease.

Authors:  Laura P W Ranum; John W Day
Journal:  Trends Genet       Date:  2004-10       Impact factor: 11.639

9.  Adenoviral-mediated, high-level, cell-specific transgene expression: a SYN1-WPRE cassette mediates increased transgene expression with no loss of neuron specificity.

Authors:  Colin P J Glover; Alison S Bienemann; Darren J Heywood; A Siobhan Cosgrave; James B Uney
Journal:  Mol Ther       Date:  2002-05       Impact factor: 11.454

10.  Mutant DMPK 3'-UTR transcripts disrupt C2C12 myogenic differentiation by compromising MyoD.

Authors:  Jeffrey D Amack; Shannon R Reagan; Mani S Mahadevan
Journal:  J Cell Biol       Date:  2002-11-11       Impact factor: 10.539

View more
  19 in total

1.  A Toxic RNA Templates the Synthesis of Its Own Fluorogenic Inhibitor by Using a Bio-orthogonal Tetrazine Ligation in Cells and Tissues.

Authors:  Alicia J Angelbello; Matthew D Disney
Journal:  ACS Chem Biol       Date:  2020-06-17       Impact factor: 5.100

2.  mRNA nuclear export and human disease.

Authors:  Jessica A Hurt; Pamela A Silver
Journal:  Dis Model Mech       Date:  2008 Sep-Oct       Impact factor: 5.758

3.  Precise small-molecule recognition of a toxic CUG RNA repeat expansion.

Authors:  Suzanne G Rzuczek; Lesley A Colgan; Yoshio Nakai; Michael D Cameron; Denis Furling; Ryohei Yasuda; Matthew D Disney
Journal:  Nat Chem Biol       Date:  2016-12-12       Impact factor: 15.040

4.  Generation of stable Xenopus laevis transgenic lines expressing a transgene controlled by weak promoters.

Authors:  Anne L'hostis-Guidet; Gaëlle Recher; Brigitte Guillet; Abdulrahim Al-Mohammad; Pascal Coumailleau; François Tiaho; Daniel Boujard; Thierry Madigou
Journal:  Transgenic Res       Date:  2009-04-30       Impact factor: 2.788

5.  Rational and modular design of potent ligands targeting the RNA that causes myotonic dystrophy 2.

Authors:  Melissa M Lee; Alexei Pushechnikov; Matthew D Disney
Journal:  ACS Chem Biol       Date:  2009-05-15       Impact factor: 5.100

6.  Rationally designed small molecules targeting the RNA that causes myotonic dystrophy type 1 are potently bioactive.

Authors:  Jessica L Childs-Disney; Jason Hoskins; Suzanne G Rzuczek; Charles A Thornton; Matthew D Disney
Journal:  ACS Chem Biol       Date:  2012-03-05       Impact factor: 5.100

Review 7.  Small molecule recognition of disease-relevant RNA structures.

Authors:  Samantha M Meyer; Christopher C Williams; Yoshihiro Akahori; Toru Tanaka; Haruo Aikawa; Yuquan Tong; Jessica L Childs-Disney; Matthew D Disney
Journal:  Chem Soc Rev       Date:  2020-10-05       Impact factor: 54.564

8.  Features of modularly assembled compounds that impart bioactivity against an RNA target.

Authors:  Suzanne G Rzuczek; Yu Gao; Zhen-Zhi Tang; Charles A Thornton; Thomas Kodadek; Matthew D Disney
Journal:  ACS Chem Biol       Date:  2013-09-13       Impact factor: 5.100

9.  Rational design of bioactive, modularly assembled aminoglycosides targeting the RNA that causes myotonic dystrophy type 1.

Authors:  Jessica L Childs-Disney; Raman Parkesh; Masayuki Nakamori; Charles A Thornton; Matthew D Disney
Journal:  ACS Chem Biol       Date:  2012-11-07       Impact factor: 5.100

10.  Rational design of ligands targeting triplet repeating transcripts that cause RNA dominant disease: application to myotonic muscular dystrophy type 1 and spinocerebellar ataxia type 3.

Authors:  Alexei Pushechnikov; Melissa M Lee; Jessica L Childs-Disney; Krzysztof Sobczak; Jonathan M French; Charles A Thornton; Matthew D Disney
Journal:  J Am Chem Soc       Date:  2009-07-22       Impact factor: 15.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.